Neoleukin Therapeutics Inc (NASDAQ:NLTX)

0.625
Delayed Data
As of Mar 24
 +0.0002 / +0.03%
Today’s Change
0.38
Today|||52-Week Range
2.32
+22.79%
Year-to-Date
No recent news for Neoleukin Therapeutics Inc.

Today’s Trading

Previous close0.62
Today’s open0.64
Day’s range0.63 - 0.66
Volume21,416
Average volume (3 months)419,505
Market cap$28.4M
Data as of 3:00pm ET, 03/24/2023

Growth & Valuation

Earnings growth (last year)-71.73%
Earnings growth (this year)+10.91%
Earnings growth (next 5 years)+16.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.19

Competitors

 Today’s
change
Today’s
% change
LUMOLumos Pharma Inc0.000.00%
----
LPCNLipocine Inc-0.02-6.06%
----
Data as of 3:57pm ET, 03/24/2023

Financials

Last reporting dateMarch 24, 2023
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$0.00
Annual profit (last year)-$60.7M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Seattle, Washington

Forecasts